Lower extremity peripheral artery disease

There are 6 papers on lower extremity peripheral artery disease in aging research: 1 trial and 2 observational studies in people, 1 review. The newest story, Nov 7, 2026: “Perceived walking gains did not always match leg symptom changes”.

Disease

6 papers study it37 more mention it2 findings

6 new papers in 30 daysSee all 43 papers on lower extremity peripheral artery disease

“The DALY rate likewise increased from 2.20 to 2.75 per 100,000 population, a 25.4% increase, with an EAPC of 0.69% per year.”
High Fasting Plasma Glucose and the Rising Midlife Burden of Lower-Extremity Peripheral Artery Disease, 1990-2023AHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.14438
  • Human trial1
  • Humans2
  • In silico2

Effects

2

Mortality rate

upin humans1

1 study
  1. Lower extremity peripheral artery disease is linked with higher mortality rate in humans (0.054 to 0.064 deaths per 100,000 population; 579 to 1,404 deaths).

    “Deaths climbed from 579 to 1,404, and the death rate increased from 0.054 to 0.064 per 100,000 population.”

    HumansGlobal lower-extremity peripheral artery disease attributable to high fasting plasma glucose; temporal comparison1990–2023

    High Fasting Plasma Glucose and the Rising Midlife Burden of Lower-Extremity Peripheral Artery Disease, 1990-2023

    AHA Scientific Sessions 2026 abstract

Disability-adjusted life-year rate

upin humans1

1 study
  1. Lower extremity peripheral artery disease is linked with higher disability-adjusted life-year rate in humans (+25.4%; 2.20 to 2.75 per 100,000 population; EAPC 0.69% per year).

    “The DALY rate likewise increased from 2.20 to 2.75 per 100,000 population, a 25.4% increase, with an EAPC of 0.69% per year.”

    HumansGlobal lower-extremity peripheral artery disease attributable to high fasting plasma glucose; temporal comparison1990–2023

    High Fasting Plasma Glucose and the Rising Midlife Burden of Lower-Extremity Peripheral Artery Disease, 1990-2023

    AHA Scientific Sessions 2026 abstract

Funding

1 grant since 2025

Japan Society for the Promotion of Science¥4.6M

Latest

Dec 2025: 0Jan 2026: 3Feb 2026: 2Mar 2026: 1Apr 2026: 0May 2026: 2Jun 2026: 0Jul 2026: 1Aug 2026: 2Sep 2026: 5Oct 2026: 2Nov 2026: 422 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Perceived walking gains did not always match leg symptom changes

Across five trials, perceived walking-distance scores rose 10.01 points with exercise versus 3.10 with control over six months.Across five trials, perceived walking-distance scores rose 10.01 points with exercise versus 3.10 with control over six months.

Meta-analysis · 626 peopleInterventions

See all 43 papers on lower extremity peripheral artery disease